Lisa Sproat

627 total citations
18 papers, 340 citations indexed

About

Lisa Sproat is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lisa Sproat has authored 18 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Genetics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lisa Sproat's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (6 papers) and Epigenetics and DNA Methylation (4 papers). Lisa Sproat is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (6 papers) and Epigenetics and DNA Methylation (4 papers). Lisa Sproat collaborates with scholars based in United States, Germany and United Kingdom. Lisa Sproat's co-authors include James L. Slack, Veena Fauble, José F. Leis, Nandita Khera, Pierre Noël, Joseph Mıkhael, Jon C. Tilburt, Shahrukh K. Hashmi, Timothy J. Beebe and Vivek Roy and has published in prestigious journals such as Blood, Cancer and Clinical Infectious Diseases.

In The Last Decade

Lisa Sproat

17 papers receiving 338 citations

Peers

Lisa Sproat

HEMAT

PHEOH

ONCOL

Veena Fauble United States

Roman M. Shapiro United States

Bendt Nielsen Denmark

Mazin Faisal Al‐Jadiry Iraq

Tanya L. Pedersen United States

Colleen Lewis United States

Vivian Paintsil Ghana

Birgith Engelst Grove Denmark

Julia Foster United States

Susan Flesch United States

Veena Fauble United States

Lisa Sproat

168 ×1.1

HEMAT

77 ×0.8

PHEOH

30 ×0.3

53 ×0.6

ONCOL

77 ×1.0

Citations per year, relative to Lisa Sproat Lisa Sproat (= 1×) peers Veena Fauble

Countries citing papers authored by Lisa Sproat

Since Specialization

Citations

This map shows the geographic impact of Lisa Sproat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Sproat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Sproat more than expected).

Fields of papers citing papers by Lisa Sproat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Sproat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Sproat. The network helps show where Lisa Sproat may publish in the future.

Co-authorship network of co-authors of Lisa Sproat

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Sproat. A scholar is included among the top collaborators of Lisa Sproat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Sproat. Lisa Sproat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Badar, Talha, James M. Foran, Mohamed A. Kharfan‐Dabaja, et al.. (2024). Venetoclax in Combination with Hypomethylating Agent (HMA) Compared to HMA Alone Improves Response but Not Survival in TP53-mutated High-Risk Myelodysplastic Syndrome: Real-World Mayo Clinic Series. Blood. 144(Supplement 1). 1823–1823. 1 indexed citations

Tibes, Raoul, Heidi Kosiorek, Amylou C. Dueck, et al.. (2023). Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms. Cancer. 129(15). 2321–2330. 7 indexed citations

Alkhateeb, Hassan B., David S. Viswanatha, James M. Foran, et al.. (2021). Genetic features and clinical outcomes of patients with isolated and comutatedDDX41-mutated myeloid neoplasms. Blood Advances. 6(2). 528–532. 27 indexed citations

Jain, Tania, Katie L. Kunze, Luke Mountjoy, et al.. (2020). Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis. Blood Cancer Journal. 10(3). 36–36. 13 indexed citations

Buras, Matthew, José F. Leis, Pierre Noël, et al.. (2019). Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 55(6). 1175–1177. 3 indexed citations

Heckman, Michael G., Dan Zhou, Man Yang, et al.. (2016). Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML). Blood. 128(22). 1719–1719. 2 indexed citations

Jain, Tania, M’hamed Temkit, Mrinal M. Patnaik, et al.. (2016). Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis. Blood. 128(22). 4653–4653. 1 indexed citations

Finn, Laura, Lisa Sproat, Michael G. Heckman, et al.. (2015). Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy. Cancer Epidemiology. 39(6). 1084–1092. 26 indexed citations

Tibes, Raoul, Heidi Kosiorek, Amylou C. Dueck, et al.. (2015). Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies. Blood. 126(23). 1347–1347. 7 indexed citations

10.

Alkhateeb, Hassan B., Moussab Damlaj, Aref Al‐Kali, et al.. (2015). Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience. Blood. 126(23). 4910–4910.

11.

Khera, Nandita, Yu‐Hui Chang, James L. Slack, et al.. (2014). Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 56(4). 987–992. 16 indexed citations

12.

Khera, Nandita, Yu‐Hui Chang, Shahrukh K. Hashmi, et al.. (2014). Financial Burden in Recipients of Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1375–1381. 106 indexed citations

13.

Chaudhuri, Leena, James M. Bogenberger, Lisa Sproat, et al.. (2013). The Wee1 Inhibitor MK1775 In Combination With Cytarabine (AraC) Has Potent Activity In AML By Completely Abrogating DNA Damage and Cell Cycle Checkpoint Repair Capacity Via The Mrn/NBS1 Complex. Blood. 122(21). 3831–3831. 1 indexed citations

14.

Chaudhuri, Leena, Nicole D. Vincelette, Brian D. Koh, et al.. (2013). CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. Haematologica. 99(4). 688–696. 63 indexed citations

15.

Beebe, Kristen, Yu‐Hui Chang, Jane M. Palmer, et al.. (2013). Impact Of Vitamin D Level Pre and Post Allogeneic Hematopoietic Stem Cell Transplant. Blood. 122(21). 4616–4616. 4 indexed citations

16.

Khera, Nandita, Yu‐Hui Chang, Shahrukh K. Hashmi, et al.. (2013). Financial Burden In Recipients Of Allogeneic Hematopoietic Cell Transplantation. Blood. 122(21). 721–721. 32 indexed citations

17.

Mickelson, David M., Lisa Sproat, Robert M. Dean, et al.. (2010). Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. Bone Marrow Transplantation. 46(1). 84–89. 18 indexed citations

18.

Sproat, Lisa, Liron Pantanowitz, Caixia Lü, & Bruce J. Dezube. (2003). Human Immunodeficiency Virus--Associated Hemophagocytosis with Iron-Deficiency Anemia and Massive Splenomegaly. Clinical Infectious Diseases. 37(11). e170–e173. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact